TOP > News > Details

UN: CERD adopts follow-up letters to Bosnia and Herzegovina, China, Honduras, Japan, Latvia, Mauritania, Mauritius, Norway, Qatar and Saudi Arabia

Date : 2020.10.06

At the 101st session which took place online from 5th to 7th August, the UN Committee on the Elimination of Racial Discrimination (CERD) adopted follow-up letters to Bosnia and Herzegovina, China, Honduras, Japan, Latvia, Mauritania, Mauritius, Norway, Qatar and Saudi Arabia. (*The follow-up letter to China was adopted on 24th November.)

Within one year of the adoption of concluding observations, States parties are required to provide information on the implementation of the specific recommendations identified by the CERD (follow-up recommendations), in accordance with Article 9 (1) of the Convention and rule 65 of the rules of procedure.

One of the three categories (satisfactory; partially satisfactory; and not satisfactory) is applied by the CERD to assess information from States parties on the implementation of follow-up recommendations. The table below shows the follow-up recommendations to the States concerned and the CERD’s assessments.

 

Bosnia and Herzegovina (Concluding observations, State party’s follow-up report, Follow-up letter)

 

China (Concluding observations, State party’s follow-up report, Follow-up letter)

 

Honduras (Concluding observations, State party’s follow-up report, Follow-up letter)

 

Japan (Concluding observations, State party’s follow-up report, Follow-up letter)


Latvia
(Concluding observations, State party’s follow-up report, Follow-up letter)

 

Mauritania (Concluding observations, State party’s follow-up report, Follow-up letter)


Mauritius
(Concluding observations, State party’s follow-up report, Follow-up letter)


Norway
(Concluding observations, State party’s follow-up report, Follow-up letter)


Qatar
(Concluding observations, State party’s follow-up report, Follow-up letter)


Saudi Arabia
(Concluding observations, State party’s follow-up report, Follow-up letter)

Back Number

Copyright © IMADR. All Rights Reserved.